0.115
0.01 (4.55%)
| Previous Close | 0.110 |
| Open | 0.115 |
| Volume | 22,200 |
| Avg. Volume (3M) | 3,108,914 |
| Market Cap | 44,626,556 |
| Price / Sales | 1.71 |
| Price / Book | 0.260 |
| 52 Weeks Range |
| Profit Margin | -19.33% |
| Operating Margin (TTM) | -19.13% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | 2.80% |
| Total Debt/Equity (MRQ) | 15.19% |
| Current Ratio (MRQ) | 3.05 |
| Operating Cash Flow (TTM) | 11.51 M |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (MY) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | LKL | - | - |
Stockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -0.50 |
|
LKL International Bhd is a Malaysian company which is principally engaged in the provision of medical and healthcare beds, peripherals, and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities including clinics and specialist institutions. It operates its business in Malaysia, Africa, Asia, Europe, and other regions. The majority of its revenue is earned from Malaysia. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 42.01% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |